Mobile health (mHealth) is an area of electronic health (eHealth) that delivers revolutionized healthcare services through mobile technologies such as mobile phones that enable the remote monitoring of patients suffering from acute and chronic diseases. The growing prevalence of lifestyle diseases such as diabetes, obesity, hypertension, chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA), creates an impending need for technologically advanced platforms for the prevention and treatment of these diseases. According to the World Health Organization (WHO), an estimate of 3.1 million deaths occurred due to COPD in 2012, which accounted for about 5.6% of the global death toll. In 2012, nearly 6.7 million deaths occurred due to CVD stroke which accounted for about 11.9% of the global death toll. The frequent launch of smartphone based medical devices such as cardiac monitors, respiratory monitors and blood glucose monitors address the need for regular health monitoring and treatment of diseases.
The global mHealth market was evaluated at $10.5 billion in 2014, and is expected to register a high CAGR of 33.5% during the forecast period (2015 to 2020). This growth would be primarily driven by the growing prevalence of lifestyle diseases, active government initiatives and the rising adoption of smartphones, globally. Presently, the market is witnessing a resurgence due to the increased mobile penetration, which is more than 100% in developed markets. A similar trend is observed in the developing markets, namely the Asia-Pacific and Africa. The lower accuracy and the nascence of technologies, especially in developing and under-developed regions are major factors that limit the growth of the mHealth market.
The global mHealth market is segmented into devices, services, application, stakeholders and geography. Based on device type, the market is further segmented into blood glucose meters, BP monitors, pulse oximetry, neurological monitoring devices, apnea and sleep monitors, wearable fitness sensor device & heart rate meters and others. BP monitors segment holds a dominant share; however, the blood glucose meters segment is estimated to register the fastest growth in the global mHealth devices market. Factors such as rising incidences of hypertension, sedentary lifestyles, the increasing count of diabetics, supplement the adoption of mHealth devices globally. Based on services, the market is segmented into diagnosis services, monitoring services, prevention, treatment and wellness & healthcare system strengthening solutions. Monitoring services segment holds a dominant share in the global mHealth services market and would register the highest CAGR through the forecast period (2015-2020). Based on stake holders, the market is segmented into mobile operators, device vendors, healthcare providers and application players/developers. Mobile operators segment occupies a dominant share in the global mHealth stakeholders market; whereas, the mobile application developers segment would register the highest CAGR during the forecast period (2015-2020). Based on applications, the mHealth market is segmented into cardiovascular diseases, diabetes, respiratory diseases, neurological diseases and others. The cardiovascular diseases segment holds a dominant share in the global mHealth applications market; however, the diabetes application segment is expected to register the highest CAGR during the forecast period (2015-2020). Based on geography, the market is segmented across North America, Europe, Asia-Pacific and LAMEA. North America region holds the largest share; whereas, Asia Pacific would be the fastest growing region in the global mHealth market.
The key players profiled in this report include - Philips Healthcare, Omron HealthCare, Inc., Bayer Healthcare, LifeWatch AG, Masimo Corporation, Sanofi S.A., Boston Scientific Corporation, AT&T Inc. and Johnson & Johnson. Product launch and collaboration are some of the key strategies adopted by companies operating in the global mHealth market. For example, in January 2015, Masimo Corporation launched MightySat, a Fingertip Pulse Oximeter with Masimo SET Measure-through Motion and Low Perfusion Technology. In March 2015, Omron launched its smartphone enabled activity tracker and fitness app.
KEY MARKET BENEFITS:
The report covers a quantitative analysis of the current market scenario and estimations through 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities
The mHealth market scenario is comprehensively analysed based on key regions
The report profiles the prominent market players and highlights their key strategies, which helps in understanding the competitive outlook of the market
Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework
Comprehensive analysis of factors that drive and restrict the growth of the global mHealth market is provided in the report
Exhaustive analysis of the global mHealth market, by device type, helps in understanding the types of devices that are presently used, along with the variants that would gain prominence in future
KEY MARKET SEGMENTS:
Global mHealth Market- By Devices
Blood glucose meters
BP monitors
Pulse oximetry
Neurological monitoring devices
Apnea and sleep monitors
Wearable fitness sensor device & heart rate meters
Others
Global mHealth Market- By Services
Diagnosis services
Monitoring services
Prevention
Treatment
Wellness and healthcare system strengthening solutions
Global mHealth Market- By Stakeholders
Mobile operators
Device vendors
Healthcare providers
Application players
Global mHealth Market- By Application
Cardiovascular diseases
Diabetes
Respiratory diseases
Neurological diseases
Others
Global mHealth Market- By Geography
North America
US
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Russia
Rest of Europe
Asia-Pacific
Australia
Japan
China
India
Rest of Asia-pacific
LAMEA
Latin America
Middle East
Africa
Chapter: 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
Chapter: 2 EXECUTIVE SUMMARY
2.1 CXO prospective
2.2 Market beyond what expected by 2025 ($million)
2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Critical growth scenario
Chapter: 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top factors impacting global mHealth market
3.2.2 Top investment pockets- global mHealth market
3.2.3 Top winning strategies- global mHealth market
3.3 Porters five forces analysis
3.3.1 Bargaining power of buyers
3.3.2 Bargaining power of suppliers
3.3.3 Threat of new entrants
3.3.4 Threat of substitute
3.3.5 Intense competitive rivalry
3.4 Value chain analysis
3.4.1 Primary activities
3.4.2 Secondary activities
3.5 Regulatory issues, legislations and authorities
3.5.1 Regulations and Directives pertaining to mHealth in the U.S.
3.5.2 Regulations and directives pertaining to mHealth in EU
3.6 Insurance and reimbursement scenario
3.7 Market player positioning 2014
3.8 Clinical trials (2011-2015)
3.9 Patent analysis (2011-2015)
3.9.1 US patent analysis
3.9.2 Europe patent analysis
3.9.3 Japan patent analysis
3.10 Market dynamics
3.10.1 Drivers
3.10.1.1 Integration of wireless technologies with portable healthcare devices
3.10.1.2 Increase in incidences of lifestyle disease
3.10.1.3 Cost and Convenience Factors
3.10.1.4 Technological innovations
3.10.1.5 Government initiative
3.10.1.6 Affordability of smartphones
3.10.2 Restrains
3.10.2.1 Lower adoption due to lack of awareness and technology infancy in developing and under developed region
3.10.2.2 Weak reimbursement coverage
3.10.2.3 Technological awareness among the ageing population
3.10.2.4 Uncertainty in the government regulations is expected to hinder the growth rate
3.10.3 Opportunities
3.10.3.1 Untapped market of developing economies
3.10.3.2 Rising Opportunities in the form of bundled services
Chapter: 4 GLOBAL MHEALTH MARKET, BY DEVICES, 2014-2020
4.1 Blood glucose meter
4.1.1 Key market trends
4.1.2 Growth factors and opportunity
4.1.3 Market size and forecast
4.2 BP monitors
4.2.1 Key market trends
4.2.2 Growth factors and opportunity
4.2.3 Market size and forecast
4.3 Pulse oximetry
4.3.1 Key market trends
4.3.2 Growth factors and Opportunity
4.3.3 Market size and forecast
4.4 Neurological monitoring
4.4.1 Key market trends
4.4.2 Growth factors and Opportunity
4.4.3 Market size and forecast
4.5 Cardiac monitors
4.5.1 Key market trends
4.5.2 Growth factors and Opportunity
4.5.3 Market size and forecast
4.6 Apnea and sleep monitors
4.6.1 Key market trends
4.6.2 Growth factors and Opportunity
4.6.3 Market size and forecast
4.7 Wearable fitness sensor device and Heart Rate Meters
4.7.1 Key market trends
4.7.2 Growth factors and Opportunity
4.7.3 Market size and forecast
4.8 Others
4.8.1 Key market trends
4.8.2 Growth factors and opportunity
4.8.3 Market size and forecast
Chapter: 5 GLOBAL MHEALTH MARKET, BY SERVICES, 2014-2020
5.1 Prevention
5.1.1 Market size and forecast
5.2 Diagnostic services
5.2.1 Market size and forecast
5.3 Monitoring services
5.3.1 Market size and forecast
5.4 Treatment
5.4.1 Market size and forecast
5.5 Wellness and healthcare system strengthening solutions
5.5.1 Market size and forecast
Chapter: 6 GLOBAL MHEALTH MARKET, BY STAKEHOLDERS, 2014-2020
6.1 Mobile operators
6.1.1 Market size and forecast
6.2 Device vendors
6.2.1 Market size and forecast
6.3 Healthcare Providers
6.3.1 Market size and forecast
6.4 Application/ Content Players
6.4.1 Market size and forecast
Chapter: 7 GLOBAL MHEALTH MARKET, BY APPLICATION, 2014-2020
7.1 Cardiovascular
7.1.1 Market size and forecast
7.2 Diabetes
7.2.1 Market size and forecast
7.3 Respiratory
7.3.1 Market size and forecast
7.4 Neurology
7.4.1 Market size and forecast
Chapter: 8 GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2014-2020
8.1 North America
8.1.1 Key market trends
8.1.2 Key growth factors and opportunity
8.1.3 Market size and forecast
8.1.4 United States
8.1.4.1 Market size and forecast
8.1.5 Canada
8.1.5.1 Market size and forecast
8.1.6 Mexico
8.1.6.1 Market size and forecast
8.2 Europe
8.2.1 Key market trends
8.2.2 Key growth factors and opportunity
8.2.3 Market size and forecast
8.2.4 France
8.2.4.1 Market size and forecast
8.2.5 Germany
8.2.5.1 Market size and forecast
8.2.6 United Kingdom
8.2.6.1 Market size and forecast
8.2.7 Italy
8.2.7.1 Market size and forecast
8.2.8 Russia
8.2.8.1 Market size and forecast
8.2.9 Rest of Europe
8.2.9.1 Market size and forecast
8.3 Asia-Pacific
8.3.1 Key market trends
8.3.2 Key growth factors and opportunity
8.3.3 Market size and forecast
8.3.4 Australia
8.3.4.1 Market size and forecast
8.3.5 China
8.3.5.1 Market size and forecast
8.3.6 Japan
8.3.6.1 Market size and forecast
8.3.7 India
8.3.7.1 Market size and forecast
8.3.8 Rest of Asia-pacific
8.3.8.1 Market size and forecast
8.4 LAMEA
8.4.1 Key market trends
8.4.2 Key growth factors and opportunity
8.4.3 Market size and forecast
8.4.4 Latin America
8.4.4.1 Market size and forecast
8.4.5 Middle East
8.4.5.1 Market size and forecast
8.4.6 Africa
8.4.6.1 Market size and forecast
Chapter: 9 COMPANY PROFILES
9.1 LifeWatch AG
9.1.1 Company overview
9.1.2 LifeWatch AG snapshot
9.1.3 Operating business segment overview
9.1.4 Business performance
9.1.5 Strategic moves and development
9.1.6 SWOT analysis of LifeWatch AG
9.2 Masimo Corporation
9.2.1 Company overview
9.2.2 Masimo Corporation snapshot
9.2.3 Operating business segment overview
9.2.4 Business performance
9.2.5 Strategic moves and developments
9.2.6 SWOT analysis of Masimo Corporation
9.3 Omron healthcare
9.3.1 Company overview
9.3.2 Omron Healthcare snapshot
9.3.3 Operating business segment overview
9.3.4 Business performance
9.3.5 Strategic moves and developments
9.3.6 SWOT analysis of Omron Healthcare Inc.
9.4 Philips healthcare (a division of Royal Philips company)
9.4.1 Company overview
9.4.2 Philips Healthcare snapshot
9.4.3 Operating business segment overview
9.4.4 Business performance
9.4.5 Strategic moves and developments
9.4.6 SWOT analysis of Philips Healthcare
9.5 Bayer healthcare (a division of Bayer)
9.5.1 Company overview
9.5.2 Bayer Healthcare snapshot
9.5.3 Operating Business Segment overview
9.5.4 Business performance
9.5.5 Strategic moves and development
9.5.6 SWOT Analysis Of Bayer Healthcare
9.6 Sanofi
9.6.1 Company overview
9.6.2 Sanofi snapshot
9.6.3 Operating business segment overview
9.6.4 Business performance
9.6.5 Strategic moves and developments
9.6.6 SWOT analysis of Sanofi
9.7 Boston Scientific Corporation
9.7.1 Company overview
9.7.2 Boston Scientific Corporation snapshot
9.7.3 Operating business segment
9.7.4 Business performance
9.7.5 Strategic moves and developments
9.7.6 SWOT analysis of Boston Scientific Corporation
9.8 AT&T Inc.
9.8.1 Company overview
9.8.2 AT&T Inc. snapshot
9.8.3 Operating business segment
9.8.4 Business performance
9.8.5 Strategic moves and developments
9.8.6 SWOT analysis of AT&T Inc.
9.9 JOHNSON & JOHNSON
9.9.1 Company overview
9.9.2 Johnson & Johnson Inc. snapshot
9.9.3 Operating business segment overview
9.9.4 Business performance
9.9.5 Strategic moves and developments
9.9.6 SWOT analysis of Johnson & Johnson Inc.
LIST OF FIGURES
FIG. 1 IMPACT ANALYSIS OF GLOBAL MHEALTH MARKET IN MODERATE GROWTH SCENARIO
FIG. 2 IMPACT ANALYSIS OF GLOBAL MHEALTH MARKET IN RAPID GROWTH SCENARIO
FIG. 3 IMPACT ANALYSIS OF GLOBAL MHEALTH MARKET IN CRITICAL GROWTH SCENARIO
FIG. 4 TOP IMPACTING FACTORS OF GLOBAL MHEALTH MARKET 2014-2020
FIG. 5 TOP INVESTMENT POCKETS
FIG. 6 TOP WINNING STRATEGIES
FIG. 7 PORTER’S FIVE FORCES ANALYSIS
FIG. 8 VALUE CHAIN ANALYSIS OF GLOBAL MHEALTH MARKET
FIG. 9 MARKET PLAYER POSITIONING 2014
FIG. 10 PATENT ANALYSIS, BY GEOGRAPHY, 2011-2015
FIG. 11 US PATENT ANALYSIS
FIG. 12 EUROPE PATENT ANALYSIS
FIG. 13 JAPAN PATENT ANALYSIS
FIG. 14 GLOBAL PER CAPITA SMARTPHONE PENETRATION (2011-2018)
FIG. 15 ESTIMATED DEATH DUE TO CVDS (MILLION)
FIG. 16 PENETRATION OF SMARTPHONE USERS BY APPLICATIONS
FIG. 17 MHEALTH INITIATIVE BY WORLD HEALTH ORGANIZATION
FIG. 18 SMARTPHONE OWNERSHIP IN UNITED STATES (2011-2014)
FIG. 19 HEART RATE MONITORS
FIG. 20 DEATHS DUE TO CVD
FIG. 21 ASTHMA PREVALENCE IN UNITED STATES IN 2011
FIG. 22 CANADIAN’S OPINION ABOUT HEALTHCARE SYSTEM
FIG. 23 BUSINESS PERFORMANCE OF LIFEWATCH 2012-2014 ($MILLION)
FIG. 24 REVENUE BY BUSINESS SEGMENT (2014)
FIG. 25 REVENUE BY REGION (2014)
FIG. 26 SWOT ANALYSIS OF LIFEWATCH AG
FIG. 27 BUSINESS PERFORMANCE OF MASIMO 2012-2014 ($MILLION)
FIG. 28 SWOT ANALYSIS OF MASIMO CORPORATION
FIG. 29 NET SALES OF OMRON ($MILLION)
FIG. 30 OMRON’S NET SALES BY OPERATING SEGMENT (2013)
FIG. 31 OMRON’S NET SALES BY REGION (2013)
FIG. 32 SWOT ANALYSIS OF OMRON HEALTHCARE INC.
FIG. 33 PHILIPS NET SALES 2012-2014 ($MILLION)
FIG. 34 PHILIPS HEALTHCARE REVENUE BY OPERATING SEGMENT (2014)
FIG. 35 SWOT ANALYSIS OF PHILIPS HEALTHCARE
FIG. 36 NET SALES OF BAYER HEALTHCARE 2012-2014 ($MILLION)
FIG. 37 BAYER HEALTHCARE’S REVENUE BY OPERATING SEGMENT IN 2014
FIG. 38 SWOT ANALYSIS OF BAYER HEALTHCARE
FIG. 39 NET SALES OF SANOFI 2012-2014 ($MILLION)
FIG. 40 NET SALES OF SANOFI BY OPERATING SEGMENT (2014)
FIG. 41 NET SALES OF SANOFI BY GEOGRAPHY 2014
FIG. 42 SWOT ANALYSIS OF SANOFI
FIG. 43 OPERATIONAL SALES OF BOSTON SCIENTIFIC 2012-2014 ($MILLION)
FIG. 44 OPERATIONAL SALES BY OPERATING SEGMENT 2014
FIG. 45 SWOT ANALYSIS OF BOSTON SCIENTIFIC CORPORATION
FIG. 46 REVENUE OF AT&T INC. 2012-2014 ($MILLION)
FIG. 47 SWOT ANALYSIS OF AT&T INC.
FIG. 48 NET SALES OF JOHNSON & JOHNSON 2012-2014 ($MILLION)
FIG. 49 NET SALES BY OPERATING SEGMENT 2014
FIG. 50 SWOT ANALYSIS OF JOHNSON & JOHNSON INC.
LIST OF TABLES
TABLE 1 GLOBAL MHEALTH MARKET BY GEOGRAPHY, MODERATE GROWTH SCENARIO, 2020 – 2025, ($MILLION)
TABLE 2 GLOBAL MHEALTH MARKET BY GEOGRAPHY, RAPID GROWTH SCENARIO, 2020 – 2025, ($MILLION)
TABLE 3 GLOBAL MHEALTH MARKET BY GEOGRAPHY, CRITICAL GROWTH SCENARIO, 2020 – 2025, ($MILLION)
TABLE 4 CLINICAL TRIALS 2011-2015
TABLE 5 PATENT ANALYSIS- UNITED STATES (2011-2014)
TABLE 6 PATENT ANALYSIS- EUROPE (2011-2014)
TABLE 7 PATENT ANALYSIS- JAPAN (2011-2014)
TABLE 8 GLOBAL MHEALTH MARKET, BY DEVICES, 2014-2020 ($MILLION)
TABLE 9 DIABETES RELATED SMART PHONE APPLICATIONS
TABLE 10 GLOBAL MHEALTH BLOOD GLUCOSE METERS MARKET, BY GEOGRAPHY, 2014 – 2020($MILLION)
TABLE 11 MOBILE COMPATIBLE BP MONITORS
TABLE 12 GLOBAL MHEALTH BP MONITORS MARKET, BY GEOGRAPHY, 2014 – 2020 ($MILLION)
TABLE 13 AVAILABLE PULSE OXIMETERS AND ITS COST
TABLE 14 GLOBAL MHEALTH PULSE OXIMETERY MARKET, BY GEOGRAPHY, 2014 – 2020 ($MILLION)
TABLE 15 GLOBAL MHEALTH NEUROLOGICAL MONITORS MARKET, BY GEOGRAPHY, 2014 – 2020 ($MILLION)
TABLE 16 GLOBAL MHEALTH CARDIAC MONITORS MARKET, BY GEOGRAPHY, 2014 – 2020 ($MILLION)
TABLE 17 SLEEP AND APNEA DEVICES
TABLE 18 GLOBAL MHEALTH APNEA & SLEEP MONITORS MARKET, BY GEOGRAPHY, 2014 – 2020 ($MILLION)
TABLE 19 WEARABLE FITNESS DEVICES AND ITS COST
TABLE 20 GLOBAL MHEALTH WEARABLE FITNESS SENSOR DEVICES AND HEART RATE METERS MARKET, BY GEOGRAPHY, 2014 – 2020 ($MILLION)
TABLE 21 GLOBAL MHEALTH OTHER DEVICES MARKET, BY GEOGRAPHY, 2014 – 2020 ($MILLION)
TABLE 22 GLOBAL M-HEALTH SERVICES MARKET, BY TYPE, 2014-2020 ($MILLION)
TABLE 23 GLOBAL M-HEALTH SERVICES MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 24 SMARTPHONE APPS FOR PREVENTIVE SERVICES
TABLE 25 MOBILE HEALTHCARE SOLUTION PROVIDED BY CDAC
TABLE 26 GLOBAL MHEALTH PREVENTION SERVICE MARKET, BY GEOGRAPHY, 2014 – 2020 ($MILLION)
TABLE 27 GLOBAL MHEALTH DIAGNOSIS SERVICE MARKET, BY GEOGRAPHY, 2014 – 2020 ($MILLION)
TABLE 28 GLOBAL MHEALTH MONITORING SERVICE MARKET, BY GEOGRAPHY, 2014 – 2020 ($MILLION)
TABLE 29 GLOBAL MHEALTH TREATMENT SERVICE MARKET, BY GEOGRAPHY, 2014 – 2020 ($MILLION)
TABLE 30 GLOBAL MHEALTH WELLNESS AND HEALTHCARE SYSTEMS STRENGTHENING SOLUTIONS MARKET, BY GEOGRAPHY, 2014 – 2020 ($MILLION)
TABLE 31 GLOBAL MHEALTH MARKET, BY STAKEHOLDERS,2014 – 2020 ($MILLION)
TABLE 32 GLOBAL MHEALTH STAKEHOLDERS MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 33 GLOBAL MHEALTH MOBILE OPERATORS MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 34 GLOBAL MHEALTH DEVICE VENDORS MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 35 GLOBAL MHEALTH HEALTHCARE PROVIDERS MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 36 GLOBAL MHEALTH APPLICATION/CONTENT PLAYERS MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 37 GLOBAL MHEALTH MARKET BY APPLICATION, 2014 – 2020 ($MILLION)
TABLE 38 GLOBAL MHEALTH APPLICATION MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 39 GLOBAL MHEALTH CARDIOVASCULAR APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 40 PREVALENCE AND PROJECTIONS (DIABETES)
TABLE 41 GLOBAL MHEALTH DIABETES APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 42 GLOBAL MHEALTH RESPIRATORY APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 43 GLOBAL NUMBER OF DALYS FOR NEUROLOGICAL DISORDERS PROJECTION FOR 2015 AND 2030
TABLE 44 GLOBAL MHEALTH NEUROLOGY APPLICATION MARKET, BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 45 IMPACT ANALYSIS PENETRATING TO GEOGRAPHY 2014
TABLE 46 NORTH AMERICA MHEALTH DEVICES MARKET BY COUNTRY, 2014 – 2020 ($MILLION)
TABLE 47 UNITED STATES MHEALTH MARKET (DEVICES AND SERVICES), 2014-2020, ($MILLION)
TABLE 48 CANADA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 49 EUROPE MHEALTH DEVICES MARKET, BY COUNTRY 2014-2020, ($MILLION)
TABLE 50 EUROPE MHEALTH SERVICES MARKET, BY COUNTRY 2014-2020, ($MILLION)
TABLE 51 FRANCE MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 52 GERMANY MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 53 UNITED KINGDOM (DEVICES AND SERVICES) MHEALTH MARKET, 2014-2020, ($MILLION)
TABLE 54 ITALY MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 55 RUSSIA MHEALTH (DEVICES AND SERVICES)MARKET, 2014-2020, ($MILLION)
TABLE 56 REST OF EUROPE MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 57 ASIA-PACIFIC MHEALTH DEVICES MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 58 ASIA-PACIFIC MHEALTH SERVICES MARKET, BY COUNTRY, 2014-2020, ($MILLION)
TABLE 59 AUSTRALIA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 60 CHINA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 61 JAPAN MHEALTH (DEVICES AND SERVICES)MARKET, 2014-2020, ($MILLION)
TABLE 62 INDIA MHEALTH (DEVICES AND SERVICES)MARKET, 2014-2020, ($MILLION)
TABLE 63 REST OF ASIA-PACIFIC MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 64 LAMEA MHEALTH DEVICES MARKET, BY COUNTRY 2014-2020, ($MILLION)
TABLE 65 LAMEA MHEALTH SERVICES MARKET, BY COUNTRY 2014-2020, ($MILLION)
TABLE 66 LATIN AMERICA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 67 MIDDLE EAST MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 68 AFRICA MHEALTH (DEVICES AND SERVICES) MARKET, 2014-2020, ($MILLION)
TABLE 69 LIFEWATCH AG COMPANY SNAPSHOT
TABLE 70 MASIMO CORPORATION SNAPSHOT
TABLE 71 OPERATING SEGMENT
TABLE 72 OMRON HEALTHCARE SNAPSHOT
TABLE 73 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 74 PHILIPS HEALTHCARE SNAPSHOT
TABLE 75 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 76 BAYER HEALTHCARE SNAPSHOT
TABLE 77 OPERATING BUSINESS SEGMENT OVERVIEW
TABLE 78 SANOFI SNAPSHOT OF SANOFI
TABLE 79 OPERATING BUSINESS SEGMENTS OVERVIEW
TABLE 80 BOSTON SCIENTIFIC CORPORATION SNAPSHOT
TABLE 81 OPERATING BUSINESS SEGMENT
TABLE 82 AT&T INC. SNAPSHOT
TABLE 83 OPERATING BUSIMESS SEGMENT
TABLE 84 JOHNSON & JOHNSON INC. COMPANY SNAPSHOT
TABLE 85 OPERATING BUSINESS
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
